AUGUST 2022LIFE SCIENCES REVIEW5CXO INSIGHTSDe-risking the Preclinical Phase of Immunotherapy Drug DevelopmentLeading global CDMO, PCI has further expanded its European Biotech packaging capabilities with investment across Europe in both the UK and Ireland facilitiesChallenges And Opportunities For AI In Drug DiscoveryLAST WORD30Analytics as a competitive advantage takes 3 things ­ access, cleanliness, and actionMatt Southwick, Executive Director, Clinical Systems and Analytical Reporting, Amgen19222628Three C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientNick Thomson,Senior Director, Chemical Research and Development, Pfizer IncAnalytical Considerations for Combination ProductsJennifer L. Riter, Sr. Director, Analytical Services, West Pharmaceutical Services, Inc.IN MY OPINION08Ralph Gareus,Director, Business Development,The Jackson LaboratoryChris Dobbs,CEng., MIET,Head of Technical Engineering,PCI Pharma ServicesRobert J. Prill,Director, Data Science and AI, Computational Biology andData Sciences,Ferring Research Institute, Inc.
< Page 4 | Page 6 >